Monday, August 31, 2020 9:36:26 AM
https://tinyurl.com/y4folz3r
Deal with R&D Biocogency Labs Europe on 8/4/20!
"It is expected that this acquisition will greatly enhance Rafarma shareholder value, given Biocogency’s immense value and profitability in vibrant biotech sector and will allow Rafarma to achieve an unprecedented level of market capitalization and liquidity of shares."
INCREDIBLE NEW RAFA Companies
Including KRAS Pharma the LEADING Pharmacutical Co in Europe!!! http://kraspharma.ru/en/ http://en.bebig.ru/
Kraspharma has 600 EMPLOYEES!!! http://kraspharma.ru/en/o_kompanii/personal
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM